Following the reverse stock split, the company's common stock will continue to trade on the Nasdaq Capital Market under the symbol "BTAI" with the new CUSIP number, 09075P204. The reverse stock split ...

A paradigm-shifting study from the Centre for Addiction and Mental Health (CAMH) shows an experimental drug, GL-II-73, has the potential to restore memory and cognitive function in a mouse model of ...

The FDA says new labels will make it easier to spot harmful ingredients. A UVA nutritionist suggests taking a holistic ...

Brain cancer is the second-leading cause of death in children in the developed world. For the children who survive, standard ...

ONAPGOis the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in adults with advanced Parkinson’s ...

The new administration’s focus on the mass detention and mass deportation of migrants constitutes a reloaded version of the ...

The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated ...

The US Food and Drug Administration signed off Thursday on the first new type of pain reliever to be approved in more than ...

C&EN’s tabulation follows approvals from the FDA’s Center for Drug Evaluation and Research; therefore, it does not include blood products, gene therapies, vaccines, and other therapies that ...

MELBOURNE, Australia (AP) — Iga Swiatek's one-month suspension for failing a drug test will not be appealed ... WADA did appeal the exoneration of current men's No. 1 Jannik Sinner and a hearing ...